HOUSTON, July 07, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, is pleased to invite investors to a webinar on July 10, 2025, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature FibroBiologics’ Founder and Chief Executive Officer, P ...

[Applause] Thank you. Have you ever been marked by something that you don't quite understand but never forgot. Not a scar, not a label, but a sentence, a line someone spoke that kept echoing.Years ago, a palm reader took a child's hand and said, "This is the palm of a serpent. She will bring misfortune." No context, no explanation, just a sentence that became a quiet shadow. A sentence that will slowly turn into a silent blueprint. One that you learn to live with long before questioning it.And that's the th ...

ALACHUA, Fla. and TAMPA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Michael Dale, board director, chief executive officer, and president, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference, on Wednesday, June 11, 2025, at 2:00 p.m. ET. Webcast events can be accessed live through the Investors page at www.axogeninc.com. For t ...

Allogeneic Growth Factor Solution to Accelerate Bone Repair BELGRADE, Mont., May 28, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic and wound care disorders, today announced the commercial launch of OsteoFactor Pro™, a naturally occurring cocktail of allogeneic growth factors engineered to improve bone healing and support surgical success across orthopedic and spine procedures. ...

Lineage Cell Therapeutics (LCTX) FY 2025 Conference May 20, 2025 02:30 PM ET Speaker0 Hey. Good afternoon, everybody. I'm gonna turn this on. Good afternoon, everybody. My name is Joe Pangenis, managing director here at HC Wainwright. Welcome back to our next fireside chat. Very happy to have with us Brian Culley, chief executive officer of Lineage Cell Therapeutics. And, so thank you very much for being here. And little before this presentation, I thought of a little analogy. Think, feel like I'm in front ...

ALACHUA, Fla. and TAMPA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the first quarter ended March 31, 2025. First Quarter Financial Results First quarter revenue was $48.6 million, a 17.4% increase compared to the first quarter of 2024.For the first quarter of 2025, gross margin was 71.9%, down from 78.8% for the first ...

ALACHUA and TAMPA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report 2025 first quarter financial results on Thursday, May 8, 2025, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release. Investors interested in participating in the conference call by phone may do s ...

Shui On Land (00272) H1 2024 Earnings Call August 29, 2024 08:00 PM ET Speaker0 Good evening, ladies and gentlemen. We're sorry that there was some, technical issue a bit earlier, so we are restarting again. Welcome again to Xiongn Land's twenty twenty four Interim Results Analyst Briefing. And thank you very much for having the patience and joining us this evening. We are pleased to have five members of the senior management team with us today. Mr. Vincent Lo, our Chairman Ms. Stephanie Lo, our Vice Chairm ...

Shui On Land (00272) H2 2023 Earnings Call March 20, 2024 08:00 PM ET Speaker0 Good evening, ladies and gentlemen. Welcome to ShoeiON Land's twenty twenty three Annual Results Analyst Briefing. Thank you very much for joining us online this evening. We are pleased to have five members of the senior management team with us today: Mr. Vincent Lo, our Chairman Ms. Stephanie Lo, Executive Director of Shuyong Land and Vice Chairman of Shuyong Xin Tiendi Mr. Douglas Song, Chief Financial Officer and Chief Investm ...

Shui On Land (00272) H1 2023 Earnings Call August 21, 2023 08:00 PM ET Speaker0 Good evening, ladies and gentlemen. Welcome to Shireon Land's twenty twenty three Interim Results Analyst Briefing. Thank you very much for joining us online this evening. We are pleased to have five members of the senior management team with us today, Mr. Vincent Lo, our Chairman Ms. Stephanie Lo, Executive Director of Shuyong Land and Vice Chairman of Shuyong Xin TianD Mr. Douglas Song, Chief Financial Officer and Chief Invest ...